AI Breakthrough Predicts Blindness Years Before Doctors Can Detect It

For centuries, blindness has been one of humanity's most feared disabilities - stripping people not only of sight but of independence, careers, and confidence. Now, a new breakthrough suggests artificial intelligence (AI) may soon step in as one of the most powerful tools to prevent avoidable blindness.

At the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), researchers unveiled a revolutionary AI system capable of predicting vision loss years before current medical tools can. By analyzing eye scans, the algorithm can spot which patients with keratoconus - a leading cause of corneal blindness - are at high risk of progression and who can be safely monitored without immediate treatment.

This breakthrough could save countless people from losing their sight, reduce the need for invasive corneal transplants, and reshape the future of eye care worldwide.

What is Keratoconus, and Why Does it Matter?

Keratoconus may not be as widely recognized as cataracts or glaucoma, but it's a serious and surprisingly common condition. Affecting up to 1 in 350 people, it usually begins in teenage years or young adulthood - a time when most are planning careers, studies, and families.

The condition occurs when the cornea, the eye's transparent front window, begins to thin and bulge outward into a cone-like shape. This distorts vision, making tasks like reading, driving, or recognizing faces difficult.

• Mild cases can be managed with glasses or contact lenses.
• Severe cases may require corneal cross-linking (a treatment that strengthens the cornea with ultraviolet light and vitamin B2 drops).
• Advanced cases often end in corneal transplants - major surgery with long recovery and potential complications.

The problem? Doctors currently can't reliably predict who will get worse. As a result, patients undergo years of frequent monitoring, and many only receive treatment after irreversible damage is already done.

How AI Changes the Game

Researchers at Moorfields Eye Hospital NHS Foundation Trust and University College London (UCL) decided to tackle this problem with AI. They trained an algorithm using a massive dataset:

• 36,673 eye scans (optical coherence tomography images, or OCTs)
• 6,684 patients monitored over years combining these scans with patient data, the AI learned to identify patterns invisible to the human eye - tiny early warning signs that predict whether keratoconus will stay stable or deteriorate rapidly.

The results were extraordinary:

From a single first visit, the AI could separate patients into low-risk (no urgent treatment) and high-risk (early intervention needed) groups.

With data from just one more visit, accuracy jumped to nearly 90%.

That means doctors could soon know from day one which patients require prompt cross-linking and which can avoid years of unnecessary stress and checkups.

Why This Matters for Patients

Imagine being a 17-year-old told you have keratoconus. Right now, that usually means:

• Years of uncertainty.
• Regular hospital visits for repeat scans.
• No clear answer on whether you'll need surgery or if your vision will worsen.

With AI, the conversation changes:

High-risk patients can be offered early cross-linking before vision deteriorates.

Low-risk patients can be reassured, saving them anxiety, money, and endless clinic trips.

“This could transform keratoconus care,” says Dr. Shafi Balal, who led the study.“Instead of waiting for sight loss, we can intervene early - preserving vision and avoiding unnecessary treatments.”

A Closer Look at the Treatment

Corneal cross-linking is currently the gold-standard treatment. The procedure:

• Vitamin B2 (riboflavin) drops are applied to the cornea.
• Ultraviolet (UV) light is shone on the eye.
• This strengthens and“cross-links” collagen fibers, halting further bulging.

The procedure is over 95% effective if done before scarring sets in. The challenge has always been knowing when to treat - too early risks unnecessary intervention, too late risks vision loss. AI could finally solve this dilemma.

The Broader Impact on Eye Care

Keratoconus is the leading reason for corneal transplants in the Western world. Transplants are resource-heavy, with long waiting lists in many countries. Preventing even a fraction of these through early AI-driven prediction could:

• Reduce surgical demand dramatically.
• Free up specialists to focus on urgent cases.
• Cut healthcare costs tied to lifelong management of blindness.

It's not just about money - it's about independence. Someone who avoids blindness keeps their career, driving license, and ability to live without constant support.

AI in Medicine: A Bigger Picture

This study is part of a growing wave of AI breakthroughs in healthcare. Recent advances include:

• AI predicting heart disease risks years before symptoms.
• AI reading mammograms more accurately than human radiologists.
• AI identifying rare eye diseases in seconds.

What sets this research apart is its scale and accuracy - tens of thousands of scans, real-world patients, and prediction accuracy near 90%.

As Dr. José Luis Güell of the Instituto de Microcirugía Ocular in Barcelona, who was not involved in the study, put it:“This technology could prevent vision loss before it happens, saving young patients from a lifetime of complications. It's one of the most promising uses of AI I've seen in eye care.”

What Comes Next?

The research team is now developing a more powerful algorithm, trained on millions of scans from multiple hospitals worldwide. The next steps include:

• Expanding to predict other eye diseases like glaucoma and macular degeneration.
• Ensuring the algorithm works across different scanning machines.
• Regulatory safety testing before clinical rollout.

If successful, doctors may soon sit down with patients, run a quick eye scan, and within minutes know their future risk of blindness - something that was unthinkable just a few years ago.

A New Era in Preventing Blindness

Blindness has always been something doctors fought after it began. Now, AI is flipping that timeline - giving medicine the ability to act before patients lose sight.

For people with keratoconus, this could mean the difference between a lifetime of vision and a lifetime of shadows.

MENAFN15092025007385015968ID1110061495